Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma

Published:2021-12-01 Issue:34 Volume:39 Page:3773-3777
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Hall William A.¹²^ORCID,Dawson Laura A.³,Hong Theodore S.⁴^ORCID,Palta Manisha⁵^ORCID,Herman Joseph M.⁶,Evans Douglas B.²^ORCID,Tsai Susan²,Ferrone Cristina R.⁷,B. Fleming Jason⁸^ORCID,Chang Daniel T.⁹^ORCID,Crane Christopher¹⁰,Koong Albert C.¹¹^ORCID,Oar Andrew¹²,Parikh Parag¹³,Erickson Beth¹²,Hoffe Sarah⁸,Goodman Karyn A.¹⁴^ORCID

Affiliation:

1. Medical College of Wisconsin, Department of Radiation Oncology and the LaBahn Pancreatic Cancer Program, Milwaukee, WI

2. Medical College of Wisconsin, Department of Surgery and the LaBahn Pancreatic Cancer Program, Milwaukee, WI

3. Radiation Medicine Program, Princess Margaret Cancer Centre; Department of Radiation Oncology, University of Toronto, Toronto, Canada

4. Massachusetts General Hospital, Department of Radiation Oncology, Boston, MA

5. Duke University, Department of Radiation Oncology, Durham, NC

6. Northwell Health, Department of Radiation Oncology, New Hyde Park, NY

7. Massachusetts General Hospital, Department of Surgery, Boston, MA

8. Moffitt Cancer Center, Department of Surgery, Tampa, FL

9. Stanford Health Care, Department of Radiation Oncology, Stanford, CA

10. Memorial Sloan-Kettering Cancer Center, Department of Radiation Oncology, New York, NY

11. MD Anderson Cancer Center, Department of Radiation Oncology, Houston, TX

12. Gold Coast University Hospital, Gold Coast, Queensland, Australia

13. Henry Ford Health System, Department of Radiation Oncology, Detroit, MI

14. Mount Sinai Hospital, Department of Radiation Oncology, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01220

Reference34 articles.

1. Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma

2. Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer

3. The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma

4. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study

5. Preoperative chemoradiotherapy to improve overall survival in pancreatic cancer: Long-term results of the multicenter randomized phase III PREOPANC trial.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design;Future Oncology;2024-01-24

2. The Use of MR-Guided Radiation Therapy for Pancreatic Cancer;Seminars in Radiation Oncology;2024-01

3. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer;Nature Reviews Gastroenterology & Hepatology;2023-11-30

4. Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy;HPB;2023-09

5. Neoadjuvant therapy for pancreatic cancer;Nature Reviews Clinical Oncology;2023-03-17